Study: Bone morphogenetic proteins don’t improve pediatric spinal fusion outcomes

New York City-based Hospital for Special Surgery researchers studied the effect of using bone morphogenetic proteins in pediatric spinal fusion. The FDA has not approved BMP use in children, however, up to 17 percent of pediatric spinal fusions use BMP off-label.

Advertisement

Researchers pulled Statewide Planning and Research Cooperative System data for New York. The study included 7,312 children and adolescents who underwent spinal fusion between 2004 and 2014.

 

Journal of Pediatric Orthopedics published the study. Researchers also presented the study at the American Academy of Orthopaedic Surgeons annual meeting in San Diego on March 14, 2017.

 

Here are four insights:

 

1. Of the patients, 6.7 percent received BMP.

 

2. Researchers noted BMP use was greater in children who were older, white or of a higher socioeconomic status.

 

3. The study authors concluded BMP use did not improve pediatric spinal fusion revision rates.

 

4. Based on their study, researchers caution against using BMP in pediatric spinal fusion.

 

More articles on spine:
High vs. low volume spinal fusion surgeons: 5 key notes on cost & quality
Shared decision making boosts spine, orthopedic patient experience & outcomes — 5 notes
Invibio: FDA reclassified semi-rigid spinal stabilization systems providing new possibilities for treating patients

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spine

Advertisement

Comments are closed.